US 11498970
Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11498970 (Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/39541, A61K39/3955